Jinling Hospital, China
4 clinical trials · 4 recruiting · OTHER
Trials by Jinling Hospital, China
RECRUITINGPhase 2NCT07175480
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
This phase 2 trial aims to test the feasibility and efficiency of PET/CT-directed treatment interruption strategy in metastatic renal cell carcinoma patients with IMDC...
Sponsor: Jinling Hospital, ChinaEnrolling: 301 location
Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)
RECRUITINGNCT07062952
Kidney-protective Intervention With Salt Substitute After Kidney Tumor Surgery
This clinical trial is an open-label, randomized controlled study designed to evaluate the efficacyand safety of salt substitutes in protecting renal function after kidney tumor...
Sponsor: Jinling Hospital, ChinaEnrolling: 2001 location
Kidney TumorsCKDSalt Substitute+2
RECRUITINGPhase 4NCT06139692
Comparison of Perioperative Conscious Sedation During Endovascular Thrombectomy in Acute Ischemic Stroke
This study aims to conduct a multicenter, prospective, randomized clinical trial to scientifically evaluate the safety and efficacy of different perioperative sedation methods...
Sponsor: Jinling Hospital, ChinaEnrolling: 8102 locations
Acute Ischemic Stroke
RECRUITINGNCT06619808
Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases
The goal of this clinical trial is to learn if hyperbaric oxygen therapy (HBOT) works to treat Metabolic Dysfunction-associated Steatotic Liver Diseases (MASLD). The main...
Sponsor: Jinling Hospital, ChinaEnrolling: 1501 location
Metabolic Dysfunction-associated Steatotic Liver DiseaseHepatic SteatosisNon-alcoholic Fatty Liver Diseases